STA-4783 News
Most Popular STA-4783 Story
Synta scores $1.1B deal with GSK
Synta Pharmaceuticals broke the billion-dollar mark in its new licensing deal with GlaxoSmithKline. Glaxo has agreed to pay Synta $80 million up front and up to $1.1 billion in total for the deal... Read more...
Latest Headlines
- October 10, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
